A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). (Q44537476)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). |
scientific article published in January 2003 |
Statements
1 reference
A low-calcemic vitamin D analog (Ro 25-4020) inhibits the growth of LNCaP human prostate cancer cells with increased potency by producing an active 24-oxo metabolite (Ro 29-9970). (English)
1 reference
Srilatha Swami
1 reference
Xian-Yan Zhao
1 reference
Stephen Sarabia
1 reference
Mei-Lung Siu-Caldera
1 reference
Milan Uskokovic
1 reference
Satya G Reddy
1 reference
David Feldman
1 reference
1 January 2003
1 reference
1 reference
164
1 reference
349-352
1 reference
Identifiers
1 reference